Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases

Gut

Volumn 43, Issue 2, 1998, Pages 182-186

  Basso, D ^a   Navaglia, F ^a   Brigato, L ^a   Piva, M G ^a   Toma, A ^a   Greco, E ^a   Di Mario, F ^a   Galeotti, F ^a   Roveroni, G ^a   Corsini, A ^a   Plebani, M ^a,b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b Servizio di Medicina di Laboratorio   (Italy)

Author keywords

cagA; Gastric adenocarcinoma; Helicobacter pylori; vacA; Western blot

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; DUODENITIS; DUODENUM ULCER; FEMALE; GASTRITIS; GENE FREQUENCY; GENETIC POLYMORPHISM; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH ULCER;

EID: 15644371883     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.2.182     Document Type: Article

References (36)

1. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6736-40.
2. Hansson L-E, Engstrand L, Nyren O, et al. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993;105:1098-103.
3. Nightingale TE, Gruber J. Helicobacter and human cancer. J. Natl Cancer Inst 1994;86:148-52.
4. Asaka M, Kimura T, Kato M, et al. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 1994;73:2691-4.
5. Hwang H, Dwyer J, Russel RM. Diet, Helicobacter pylori infection, food preservation and gastric cancer risk: are there new roles for preventative factors? Nutr Rev 1994;52: 75-83.
6. Craanen ME, Blok P, Dekker W, et al. Helicobacter pylori and early gastric cancer. Gut 1994;35:1372-4.
7. Kuipers EJ, Meuwissen SGM. Helicobacter pylori and gastric carcinogenesis. Scand J Gastroenterol 1996;31(suppl 218):103-5.
8. Forman D. Helicobacter pylori and gastric cancer. Scand J Gastroenterol 1996;31(suppl 220):23-6.
9. Nedrud JG, Czinn SJ. Helicobacter pylori. Curr Opin Gastroenterol 1997;13:71-8.
10. Hirai M, Azuma T, Ito S, et al. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric carcinoma patients. Int J Cancer 1994;56:56-60.
11. Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 1995;55:562-5.
12. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-15.
13. Mitchell HM, Hazell SL, Li YY, et al. Serological response to specific Helicobacter pylori antigens: antibody against cagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol 1996;91:1785-8.
14. Parsonnet J, Friedman GD, Orentreich N, et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997;40:297-301.
15. Brenes F, Ruiz B, Correa P, et al. Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 1993;88:1870-5.
16. Vollmers HP, Dammrich J, Ribbert H, et al. Human monoclonal antibodies from stomach carcinoma patients react with Helicobacter pylori and stimulate stomach cancer cells in vitro. Cancer 1994;74:1525-32.
17. Murakami K, Fujioka T, Kodama R, et al. Helicobacter pylori infection accelerates human gastric mucosal cell proliferation. J Gastroenterol 1997;32:184-8.
18. Plebani M, Basso D, Cassaro M, et al. Helicobacter pylori serology in patients with chronic gastritis. Am J Gastroenterol 1996;91:954-8.
19. Davies GR, Simmonds NJ, Stevens TRJ, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994;35:179-85.
20. Banerjee S, Hawksby C, Miller S, et al. Effect of Helicobacter pylon and its eradication on gastric juice ascorbic acid. Gut 1994;35:317-22.
21. Baik S-C, Youn H-S, Chung M-H, et al. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res 1996;56:1279-82.
22. Labenz J, Borsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut 1994;35:19-22.
23. Bayerorffer K, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995;345:1591-4.
24. Fontham ETH, Ruiz B, Perez A, et al. Determinants of Helicobacter pylori infection and chronic gastritis. Am J Gastroenterol 1995;90:1094-101.
25. Cover TL. The vacuolating cytotoxin of Helicobacter pylori. Mol Microbiol 1996;20:241-6.
26. Atherton JC, Cao P, Peek RM, et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995;270:17771-7.
27. Crabtree JE, Wyatt JI, Sobala GM, et al. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993;34:1339-43.
28. Cover TL, Glupczynski Y, Lage AP, et al. Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol 1995;33:1496-500.
29. Basso D, Navaglia F, Cassaro M, et al. Gastric juice polymerase chain reaction: an alternative to histology in the diagnosis of Helicobacter pylori infection. Helicobacter 1996;1:159-61.
30. Shibata T, Imoto I, Ohuchi Y, et al. Helicobacter pylori infection in patients with gastric carcinoma in biopsy and surgical resection specimens. Cancer 1996;77:1044-9.
31. Shibata T, Imoto I, Gabazza HC. Detection of Helicobacter pylori in biopsy of patients with gastric carcinoma. Biomed Pharmacother 1997;51:22-8.
32. Navaglia F, Basso D, Piva MG, et al. Helicobacter pylori cytotoxic genotype is associated with peptic ulcer and influences serology. Am J Gastroenterol 1998;93:227-30.
33. Peek RM, Miller GG, Tham KT, et al. Heightned inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 1995;71:760-70.
34. Yamaoka Y, Kita M, Kodama T, et al. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996;110:1744-52.
35. Atherton JC, Peek RM, Tham KT, et al. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997;112:92-9.
36. Klaamas K, Held M, Wadstrom T, et al. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer 1996;67:1-5.